How this year’s Medicare drug price negotiations could affect the pharmaceutical industry.
Insights
Our latest thinking on the themes shaping today’s investment landscape. Explore timely updates, quarterly features and in-depth analysis straight from our experts.
Strong performance from Japanese larger companies is setting the scene for small and mid-cap stocks to shine given their potential for relatively higher growth.
Portfolio Manager Jamie Ross discusses the European Central Bank's decision to lower interest rates for the second time in 2024.
The drivers of emerging market equity returns are evolving as innovation and economic decoupling join favorable demographics as future sources of excess returns.
This week's chart to watch spotlights the contrast between U.S. rate cut expectations and the broad economic growth trajectory.
Global dividends rose to a record US$606.1 billion, up 8.2% on an underlying basis.
Why investors looking to diversify equity portfolios may want to consider these long-discounted financials.
The legacy of the GFC has perpetuated misunderstanding around the European securitised market. What is the reality and how has the sector changed?
Hear how AI and other advances in healthcare are transforming patient outcomes and leading to new investment opportunities.
Unloved and undervalued – but with peak interest rates seemingly behind us in this cycle, are small caps well placed to benefit? The PCS Team considers the prospects for small caps.
Signals embedded in options markets indicate a closer race for the White House than suggested by consensus polling data.